foxo4-dri senolytic 2023 2024 study

foxo4-dri senolytic 2023 2024 study Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Targeting Cellular Senescence in Aging

Name: foxo4-dri senolytic 2023 2024 study Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Targeting Cellular Senescence in Aging
Brand: www.bohnert.fr
SKU: 76070774027
Price: 27.23 USD
Availability: InStock
Rating: 4.2007 (14 reviews)

SKU: 76070774027

4.2

USD27.23 USD65.23

Pay in 4 interest-free payments of $6.81 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 29 - Aug 3

Description

Peptides are long, delicate chains of amino acids

19 BayroM

Steroids have a risk of side-effects, including founder in certain populations of horses, as well as damage to the cartilage through ongoing use

Compound GHK-Cu (Copper Tripeptide-1) CAS Number 89030-95-5 Sequence Gly-His-Lys (copper-bound) Molecular weight ~403.9 g/mol Purity 99% (HPLC verified) Form Lyophilised powder Contents 50mg or 100mg per vial Packaging Sealed sterile research vial Storage (lyophilised) 28C, protect from light & moisture Storage (reconstituted) 28C, use within 28 days Reconstitution Bacteriostatic water (recommended)